Apellis Pharmaceuticals, Inc. (APLS) Earnings
|
Expand Research on APLS
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +36.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | -$0.35 | N/A | N/A | $203.21M | N/A | N/A | N/A | ||
| 2/24/26 | Q425 | $0.47 | -$0.38 | +$0.85 | $199.91M | $198.82M | N/A |  | | Details | |
| 10/30/25 | Q325 | $1.67 | $1.55 | +$0.12 | $458.6M | $450.97M | N/A | | | Details | |
| 7/31/25 | Q225 | -$0.33 | -$0.48 | +$0.15 | $178.49M | $186.76M | N/A | | | Details | |
| 5/7/25 | Q125 | -$0.74 | -$0.34 | -$0.40 | $166.8M | $197.77M | N/A | | | Details | |
| 5/1/25 |
Q125 | N/A | -$0.34 | N/A | N/A | $197.77M | N/A | N/A | N/A | ||
| 2/28/25 | Q424 | -$0.29 | -$0.37 | +$0.08 | $212.5M | $192.9M | N/A | | | Details | |
| 11/5/24 | Q324 | -$0.46 | -$0.29 | -$0.17 | $196.83M | $200.09M | N/A | | | Details |
